QTRX
Quanterix·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 2
Ample Liquidity
Significant Net Income Decline
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About QTRX
Quanterix Corporation
A provider of innovative diagnostic tests and services for precision health
Life Science Tools and Services
--
12/07/2017
NASDAQ Stock Exchange
471
12-31
Common stock
900 Middlesex Turnpike, Billerica, MA 01821
--
Quanterix Corporation, formerly known as "Digital Genomics, Inc.", was incorporated under the laws of Delaware in April 2007. The company is a life science company that develops a new generation of ultra-sensitive digital immunoassay platforms for life science research and diagnosis. The company's platform enables customers to reliably detect protein biomarkers in very low concentrations in blood, serum and liquids, which in many cases cannot be detected using traditional simulated immunoassay techniques. These capabilities provide clients with insight into the role of protein biomarkers in human health that cannot be achieved with existing technologies, and enable researchers to unlock unique insights into the continuum between health and disease. The company currently focuses on the platform for protein detection, which it believes is an area with significant unmet needs and an area where the company has a significant competitive advantage. In addition to realizing new applications and insights in protein analysis, the company has also developed Simoa technology to detect nucleic acids in biological samples.
Company Financials
EPS
QTRX has released its 2025 Q3 earnings. EPS was reported at -0.73, versus the expected -0.53, missing expectations. The chart below visualizes how QTRX has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
QTRX has released its 2025 Q3 earnings report, with revenue of 40.23M, reflecting a YoY change of 12.34%, and net profit of -33.52M, showing a YoY change of -301.26%. The Sankey diagram below clearly presents QTRX's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
